{
  "nctId": "NCT03549104",
  "briefTitle": "A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes",
  "officialTitle": "A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With T1DM",
  "protocolDocument": {
    "nctId": "NCT03549104",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-05-12",
    "uploadDate": "2022-02-03T21:36",
    "size": 814887,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03549104/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 51,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2019-01-14",
    "completionDate": "2021-06-30",
    "primaryCompletionDate": "2021-06-30",
    "firstSubmitDate": "2018-04-24",
    "firstPostDate": "2018-06-07"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\nDiagnosis of T1DM â‰¥ 1 year, receive medical care from an endocrinologist, use insulin pump therapy or multiple daily injection (MDI), have fear of hypoglycemia (screening questionnaire), and attended a basic diabetes educational program\n\nExclusion Criteria:\n\nPregnant or breastfeeding, have received therapy specifically for fear of hypoglycemia, have a co-existing chronic illness",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "35 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Fear of Hypoglycemia",
        "description": "Change in Worry Subscale score. Fear of hypoglycemia is measured with the Worry Subscale of the Hypoglycemia Fear Survey II (HFS-II) which is an 18-item, 5-point Likert-style scale with a possible score range from 0-72. A higher score indicates greater fear of hypoglycemia.",
        "timeFrame": "Assessing change between two time points: from baseline to week 8 of intervention."
      }
    ],
    "secondary": [
      {
        "measure": "Glycemic Control",
        "description": "Change in HemoglobinA1c (A1C)",
        "timeFrame": "Assessing change between two time points: from baseline to week 8 of intervention."
      },
      {
        "measure": "Glycemic Variability",
        "description": "Change in glucose variability (continuous glucose monitor-derived, glucose (mg/dl) standard deviation. Higher numbers indicate worse glycemic variability.",
        "timeFrame": "Assessing change between two time points: from baseline to week 8 of intervention"
      }
    ],
    "other": []
  },
  "realComplexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:32:38.809Z",
  "dataSource": "ClinicalTrials.gov API v2"
}